VivoSim Labs (VIVS) Net Cash Flow (2010 - 2026)
VivoSim Labs (VIVS) posted Net Cash Flow of -$3.4 million for Q2 2026, down 549.0% on a QoQ basis from $747000.0 in Q1 2026, and down 48.6% year-over-year from -$6.5 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Net Cash Flow (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Net Cash Flow for 17 years, with the latest figure at -$3.4 million in Q2 2026.
- On a quarterly basis, Net Cash Flow fell 48.6% year-over-year to -$3.4 million in Q2 2026; TTM through Jun 2026 was -$7.4 million, a 357.5% decrease from a year earlier, with the FY2026 full-year figure at -$6.3 million, down 174.76% from the prior year.
- Net Cash Flow was -$3.4 million for Q2 2026 at VivoSim Labs, down from $747000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $10.2 million in Q1 2025, with the low at -$13.1 million in Q2 2022.
- Average Net Cash Flow over 5 years is -$1.6 million, with a median of -$2.4 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow plunged 866.59% in 2022, then surged 524.02% in 2025.
- Over 5 years, Net Cash Flow stood at $6.9 million in 2022, then plunged by 133.5% to -$2.3 million in 2023, then advanced by 13.31% to -$2.0 million in 2024, then decreased by 19.23% to -$2.4 million in 2025, then slumped by 39.75% to -$3.4 million in 2026.
- The last three Net Cash Flow figures came in at -$3.4 million (Q2 2026), $747000.0 (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -37.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -150.21 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 164.82 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 43.16 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.35 Mn |
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | -2.40 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.26 Mn |
| Mar 31, 2025 | 10.15 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | -3.01 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | -2.39 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.14 Mn |
| Jun 30, 2023 | -4.55 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Dec 31, 2022 | 6.93 Mn |
| Sep 30, 2022 | -2.30 Mn |
| Jun 30, 2022 | -13.11 Mn |
| Mar 31, 2022 | -1.59 Mn |
| Dec 31, 2021 | -3.49 Mn |
| Sep 30, 2021 | -2.22 Mn |